GeneLink Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Bernard Kasten

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure13.9yrs
CEO ownershipn/a
Management average tenure13.9yrs
Board average tenure20.7yrs

Recent management updates

No updates

Recent updates

No updates


CEO

Bernard Kasten (78 yo)

13.9yrs

Tenure

US$98,660

Compensation

Dr. Bernard L. Kasten Jr., Ph D., M.D., has been the Chief Executive Officer and President of GeneLink Inc. since December 30, 2010. Dr. Kasten serves as Chief Medical Officer of GeneWize Life Sciences, In...


Leadership Team

NamePositionTenureCompensationOwnership
Bernard Kasten
Executive Chairman13.9yrsUS$98.66kno data
Robert Ricciardi
Founder29.8yrsUS$33.00kno data
Michael Smith
COO & Interim CFO11yrsno datano data

13.9yrs

Average Tenure

77yo

Average Age

Experienced Management: GNLK.Q's management team is seasoned and experienced (13.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Bernard Kasten
Executive Chairman25.8yrsUS$98.66kno data
Robert Ricciardi
Founder29.8yrsUS$33.00kno data
Robert Kagan
Member of the Scientific Advisory Boardno datano datano data
Donald Cannon
Member of Scientific Advisory Board20.7yrsno datano data
James Simpkins
Head of Medical Advisory Board and Member of the Scientific Advisory Board20.7yrsno datano data
Harry Harrison
Member of the Scientific Advisory Boardno datano datano data
Ginny Bank
Member of Scientific Advisory Boardno datano datano data
Heather Mittiga
Member of the Scientific Advisory Boardno datano datano data
Margaret Palazzolo
Member of Scientific Advisory Board13.5yrsno datano data
Stephanie Heinrich
Member of Scientific Advisory Board13.5yrsno datano data

20.7yrs

Average Tenure

Experienced Board: GNLK.Q's board of directors are seasoned and experienced ( 20.7 years average tenure).